Clinical trials sponsored by University Medical Center Groningen

Phase breakdown

Conditions studied

Recruiting trials led by University Medical Center Groningen

• Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
  NCT06692530 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
  NCT06200311 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 80 Years · Sex: All (male and female) · 1 location
• Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial
  NCT06065124 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 70 Years · Sex: All (male and female) · 2 locations
• Biological Investigation of Explanted Endobronchial Lung Valves Study
  NCT04214587 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
  NCT05851053 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Bronchoscopic EmphysemA Treatment in THE NetherLands
  NCT02815683 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Cardiopulmonary Toxicity of Thoracic Radiotherapy
  NCT03978377 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Change in Task-related Oxygen Uptake After EBV Treatment
  NCT06702072 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC
  NCT06111807 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
  NCT07304817 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
  NCT05525338 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways
  NCT05773768 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Early Ageing During Therapy in AYA Cancer Patients
  NCT05062707 · Phase: Not specified · Ages: 18 Years to 39 Years · Sex: All (male and female) · 1 location
• Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.
  NCT07206017 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Fluorescence Imaging of IBD and RA Using Adalimumab-800CW
  NCT03938701 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
  NCT06606808 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer
  NCT03941080 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• IMPT Dose Escalation for NSCLC (HyDose)
  NCT06484491 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lung Nodule Detection Using Ultra-long FOV PET/CT
  NCT05463913 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Mechanisms of Change of Positive Interventions in Reducing Vulnerability for Depression
  NCT06145984 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• No Guts No Glory Probiotics
  NCT07606014 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors
  NCT05483400 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action
  NCT05938738 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
  NCT04642027 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: Male · 13 locations
• Potassium Correction for RAAS Optimization in Chronic Kidney Disease
  NCT06256991 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Psilocybin Therapy for Psychological Distress in Palliative Patients
  NCT06782724 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF
  NCT06199180 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
  NCT05725876 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
  NCT03034187 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Respiratory Muscles in End-stage Lung Disease: Pathophysiological Processes & Clinical Consequences
  NCT06935825 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 4 locations
• Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
  NCT05440825 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
  NCT02421718 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
  NCT07269366 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
  NCT07038304 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• The MS-CEBA Study: Determining Cognitive, Energetic, Behavioural and Affective (CEBA) Profiles in Multiple Sclerosis
  NCT06016309 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• The TASTY-steering Study
  NCT07258563 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
• Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
  NCT05479669 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
  NCT05864794 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure
  NCT06587854 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is University Medical Center Groningen recruiting for?

University Medical Center Groningen is the lead sponsor of 39 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.